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ABSTRACT
MAP kinase phosphatase-1 (MKP-1) controls
nuclear MAP kinase activity with important
consequences on cell growth or apoptosis.
MKP-1 transcription is initiated constitutively but
elongation is blocked within exon 1. It is unclear
how induction of MKP-1 is controlled. Here, we
report that the transcriptional elongation factors
P-TEFb, DSIF and NELF regulate MKP-1 transcrip-
tion in the pituitary GH4C1 cell line. Prior to
stimulation, DSIF, NELF and RNA polymerase II
(pol II) associate with the promoter-proximal region
of the MKP-1 gene upstream of the elongation block
site. Thyrotropin-releasing hormone (TRH) leads to
recruitment of P-TEFb along the whole gene and
a marked increase of DSIF and pol II downstream
of the elongation block site, whereas NELF remains
confined to the promoter-proximal region.
5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole
(DRB) an inhibitor of P-TEFb eliminated TRH stimula-
tion of MKP-1 transcription. DRB specifically
inhibited TRH-induced recruitment of DSIF and
P-TEFb to the MKP-1 gene. Furthermore, DRB
treatment eliminated TRH-induced progression
along the MKP-1 gene of pol II phosphorylated
on Ser-2 of its CTD. These results indicate that
P-TEFb is essential for gene-specific stimulated
transcriptional elongation in mammalian cells via
mechanisms which involve the activation of the
DSIF–NELF complex and Ser-2 phosphorylation
of pol II.
INTRODUCTION
MAP kinase phosphatase-1 (MKP-1) gene is an immediate
early gene (IEG) induced by various extra-cellular
stimulations. Expressed in the nucleus, MKP-1 controls
the ERK MAP kinase, a key signaling enzyme which
activates cell growth, cell diﬀerentiation and apoptosis (1).
Recent reports show that MKP-1 is involved in cardiac
hypertrophy and tumorigenesis as well as monocyte/
macrophage chemotaxis (2–4). Furthermore, MKP-1
mRNA as well as protein is over-expressed at diﬀerent
stages of breast and prostate carcinoma (5–8).
These ﬁndings underline the importance of MKP-1
for the cellular patho-physiology of many diseases.
Hence, understanding how MKP-1 transcription is
controlled may also be interesting for the medical ﬁeld,
in particular to understand emergence and progression
of breast and prostate cancers.
Eukaryotic gene transcription requires, on the one
hand, mechanisms which recruit RNA polymerase II
(pol II) and the transcription factors needed to start
transcription; on the other hand, complex mechanisms are
needed to assure the output of correctly processed
mRNA. Induction of most genes is achieved by stimulat-
ing mechanisms of transcription initiation. Studies on
transcription control focus in general on the gene
promoter, normally with the aim to identify the
responsive elements which may explain induction of
transcription. These promoter elements bind transcription
factors needed to initiate gene transcription. The MKP-1
gene promoter comprises the calcium-cAMP response
element CRE, E-box and GC-boxes. These response
elements are targets of signaling via MAP kinase cascades,
protein kinase C, cAMP, Ca
2þ, glucocorticoids and
retinoic acids which are indeed controlling MKP-1
expression (9–17).
We have reported earlier that the response elements
in the MKP-1 promoter favor initiation of transcription
already in resting cells, and that transcription of the
MKP-1 gene is mainly controlled at the level of
transcriptional elongation (18). In resting cells, pol II
transcribing the MKP-1 gene is arrested within 300bp
downstream from the transcription start site (18),
unless extra-cellular stimuli trigger mechanisms
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suggest that the level of MKP-1 mRNA is mostly
regulated via mechanisms which control elongation
of transcripts, splicing, capping and polyadenylation.
Although this is also the case for many other IEGs (19),
it is at present largely unknown how signaling controls
such mechanisms. Indeed, the control of elongation
and of RNA processing has been considered so far
mainly important to coordinate progressing elongation
with splicing and capping of the nascent
transcripts (20). Here, we address the new question
of how intracellular signals enhance transcriptional
elongation of the MKP-1 gene and thereby induce its
expression.
The C-terminal domain (CTD) of a large subunit
of pol II appears to be controlling elongation of
transcripts, splicing, capping and polyadenylation
(21–24). The CTD includes 52 repeated YSPTSPS motifs
which are extensively phosphorylated and
dephosphorylated at second and ﬁfth serine (Ser-2
and Ser-5, respectively) during the transcription cycle
of pol II (21–24). So far, various kinases which
phosphorylate the CTD have been reported; among
them positive elongation factor b (P-TEFb) has been
studied most extensively.
In in vitro transcription systems, DRB sensitivity-
inducing factor (DSIF) and negative elongation factor
(NELF) can arrest elongation of transcripts by pol II
soon after transcriptional initiation. When CTD of pol II
is phosphorylated by P-TEFb, negative regulation
by DSIF–NELF is overcome and elongation resumes
(25–30). This mechanism established for in vitro tran-
scription is reminiscent of transcriptional regulation
involving a 5block to elongation4 in eukaryotic cells.
Indeed, in Drosophila cells, NELF, DSIF and P-TEFb
associate with promoter-proximal regions of immediately
responsive heat shock genes, suggesting that these factors
regulate transcriptional elongation machinery of IEGs
(31–33). A decisive role in the p53 transcriptional
program in vivo has been demonstrated for P-TEFb
(34). NELF has been shown to regulate immediate
early expression of the junB gene (35). DSIF being
phosphorylated by P-TEFb on its C-terminal repeats
(CTRs) is important to allow progression of pol II along
the IEG c-fos demonstrated in vivo by Chromatin
immunoprecipitation (ChIP) (36). How the three elonga-
tion factors operate jointly when regulating the tran-
scription of a mammalian IEG in vivo remains to be
addressed.
In this article, we examined whether the transcriptional
elongation of the MKP-1 gene is also under the control
of the DSIF–NELF complex and P-TEFb in vivo.
We investigated how these factors are distributed on the
MKP-1 gene prior to and during thyrotropin-releasing
hormone (TRH) stimulation of pituitary cells, using ChIP
assay and quantitative real-time PCR. Our results show
that P-TEFb modulates the DSIF–NELF complex
and mediates stimulated transcriptional elongation of
the MKP-1 gene, presumably through Ser-2 phosphoryla-
tion of pol II CTD.
MATERIALS AND METHODS
Cell cultureand stimulation
Rat pituitary GH4C1 cells were usually grown in Ham’s
F-10 Gluta Max medium (GIBCO) containing 2.5% (v/v)
fetal bovine serum (FBS) and 15% (v/v) horse
serum at 378C in a humidiﬁed atmosphere of 5% CO2.
For induction of MKP-1 transcription, GH4C1 cells were
incubated in Ham’s F-10 Gluta Max serum-free medium
(SFM) for 24h and then stimulated by TRH (Roche)
at 100nM for 0–48min in the absence of serum.
For inhibition of P-TEFb, GH4C1 cells were incubated
with 30mM 5,6-dichloro-1-b-D-ribofuranosylbenzimida-
zole (DRB) (Sigma) for 2h prior to TRH treatment.
RNA preparation and real-time RT-PCR analysis
Nascent transcripts were prepared as described earlier
(37). Total RNA was extracted with an acid phenol/
guanidinium reagent (TRI-Reagent; Molecular Research
Center) according to the manufacturer’s instructions.
Nascent transcripts and total RNA were quantiﬁed by
TaqMan RT-PCR (Applied Biosystems) as described
earlier (18) using the following primers and TaqMan
probes: MKP-1 exon 1; forward primer 50-GGGACGCG
CGGTGAAG-30, reverse primer 50-GATCTTGTG
CGGTTTTTTGTGG-30, TaqMan probe 50-FAM
(6-carboxyﬂuorescein)-CCTAAGTCCTCAAGTGCTCG
CTGATCCTAATCT-TAMRA (6-carboxytetramethyl-
rhodamine)-30, MKP-1 exon 2; forward primer
50-GAAGCGTTTTCGGCTTCCT-30, reverse primer
50-TCCGGATTCTGCACTGTCA-30, TaqMan probe
50-FAM-TCAGCCTCCCGCTGAGTACTAGTGTGC-
TAMRA-30, MKP-1 exon 4; forward primer 50-CCCTG
TTCACCCCACGAA-30, reverse primer 50-GCAGCTCG
GAGAGGTTGTG-30, TaqMan probe 50-FAM-TGCCC
TGAACTACCTTCAAAGCCCCA-TAMRA-30, MKP-1
exon 1-2; forward primer 50-CGCGCTCCACTCAAGTC
TTC-30, reverse primer 50-GGTGGACTGTTTGCTGC
ACA-30, TaqMan probe 50-FAM-AGCCGAAAACGCT
TCATATCCTCCTTGG-TAMRA-30, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) exon 2-3;
forward primer 50-ATGGTGAAGGTCGGTGTGAAC-
30, reverse primer 50-GAAGGCAGCCCTGGTAACC-30.
For normalization, ampliﬁcation of 18S rRNA was
performed under the standard condition by using 18S
rRNA Predeveloped Assay Reagent (Applied Biosystems).
Chromatin immunoprecipitation (ChIP) assay
GH4C1 cells were grown on 5 10
7 cells in 175cm
2 ﬂasks.
Prior to stimulation, the cells were incubated with SFM
for 24h. Chromatin of cells stimulated by TRH for the
indicated times was cross-linked by incubation for 1h
at 48C with a ﬁnal concentration of 1% formaldehyde.
The cells were washed twice with ice-cold phosphate-
buﬀered saline (PBS), then they were scrapped in PBS with
1mM phenylmethylsulfonyl ﬂuoride (PMSF) and col-
lected by centrifugation. The cells were lysed in the
cell lysis buﬀer (10mM Tris pH 8.1, 1mM EDTA, 0.5%
NP-40, 1mM PMSF, 50mM NaF, 1mM ortho-Vanadate,
1mg/ml Aprotinin, 1mg/ml Leupeptin) and then
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lysed in the nuclear lysis buﬀer (10mM Tris pH 8.1, 1mM
EDTA, 0.5MNaCl, 1% Triton, 0.5% deoxycholate, 0.5%
Sarcosyl, 1mMPMFS, 50mMNaF, 1mM ortho-
Vanadate, 1mg/ml Aprotinin, 1mg/ml Leupeptin) and
spun down. The pelleted chromatin was suspended in
the sonication buﬀer (10mM Tris pH 8.1, 1mM EDTA,
100mM NaCl) and fragmented with a Branson soniﬁer
250 to less than 1kb on average. The amount of
chromatin was estimated based on the DNA concentra-
tion measured by OD at 260nm. The chromatin extracts
(50mg of DNA content) diluted in RIPA buﬀer (1%
TritonX-100, 0.1% SDS, 0.1% deoxycholate, 140mM
NaCl, 1mM EDTA, 10mM Tris-HCl pH 8.0, 1mM
PMSF) were pre-cleared with Protein A-Sepharose beads
(Amersham-Pharmacia) for 1h and then incubated with
5–10mg of antibody at 48C overnight. Protein A-
Sepharose beads (40ml, 50% slurry) were then added to
the mixture for 3h at 48C. The beads were washed ﬁve
times with RIPA buﬀer, one time with LiCl buﬀer (0.25M
LiCl, 0.5% NP-40, 0.5% deoxycholate, 1mM EDTA,
10mM Tris-HCl pH 8.0), and two times with TE buﬀer.
The precipitated DNA–protein complexes were subjected
to reverse cross-linking by overnight incubation at 658C
with proteinase K and 10% SDS. The DNA puriﬁed by
phenol extraction and ethanol precipitation was dissolved
in 8mM NaOH and used as a template for quantitative
real-time PCR. Real-time PCR was performed with 5mlo f
DNA solution. PCR reactions were carried out in a ﬁnal
volume of 25ml with 250nM primer pairs and SYBR
Green PCR Master Mix (Applied Biosystems) or with
250nM primer pairs, 250nM Taqman probes and
Universal PCR master mix (Applied Biosystems).
Real-time PCR was performed in triplicates in 96-well
plates with ABPrism 7700 Sequence Detection System
(Applied Biosystems). Each experiment was performed
at least three times. Immuno-precipitated DNA was
expressed as a percentage of input DNA. The percent
input for 5mock4 ChIP (no primary antibody) was
maximally 0.05% of input DNA in all the conditions
examined. Antibodies used in this experiment were as
follows: an anti-cyclin T1 polyclonal antibody (H-245)
(Santa Cruz Biotechnology), an anti-Spt5 monoclonal
antibody (BD Biosciences), an anti-NELF-A polyclonal
antibody (A-20) (Santa Cruz Biotechnology), an anti-pol
II polyclonal antibody (N-20) (Santa Cruz Biotechnology)
and anti-pol II monoclonal antibodies (H5 and H14)
(Convance).
Primers and TaqMan probes used in this experiment
were as follows: MKP-1 exon 1; forward primer 50-GGGA
CGCGCGGTGAAG-30, reverse primer 50-GATCTTG
TGCGGTTTTTTGTGG-30, TaqMan probe 50-FAM-
CCTAAGTCCTCAAGTGCTCGCTGATCCTAATCT-
TAMRA-30 MKP-1 exon 1b; forward primer 50-CTTCTG
GATTGTCGCTCCTTCT-30, reverse primer 50-CGTTC
ACTGAGCCCACGAT-30, MKP-1 exon 4; forward
primer 50-CCCTGTTCACCCCACGAA-30, reverse
primer 50-GCAGCTCGGAGAGGTTGTG-30, TaqMan
probe 50-FAM-TGCCCTGAACTACCTTCAAAGCC
CCA-TAMRA-30, GAPDH 50; forward primer 50-CTCT
CTGCTCCTCCCTGTTCTA-30, reverse primer 50-CTG
GCACTGCACAAGAAGA-30, GAPDH 30; forward
primer 50-GGGCAGCCCAGAACATCA-30, reverse
primer 50-CCGTTCAGCTCTGGGATGAC-30, TaqMan
probe 50-FAM-CCCTGCATCCACTGGTGCTGCC-
TAMRA-30.
RESULTS
TRH induces rapidlyamarked and sustained increase inthe
rate ofMKP-1 transcription
The induction of the MKP-1 gene by TRH is reﬂected by a
progressive increase in transcription rate (Figure 1).
Nascent transcripts reached maximal levels between 12
and 24min. Elevated nascent transcript levels are
sustained for at least 48min. The kinetics of the increase
in nascent transcripts indicates a very rapid acceleration of
MKP-1 transcription rate. To monitor nascent transcripts
by RT-PCR, random primers are used for reverse
transcription, an approach which favors long transcripts.
Indeed, the data in Figure 1 do not clearly indicate a
higher abundance of the very short transcripts which
would be anticipated if a block to elongation in exon 1
would stop transcription as was suggested from in vitro
investigations (e.g. 18). In spite of this, the immediate
onset of the rise in transcriptional rate is consistent with
the proposal that MKP-1 transcription does not need to
be initiated de novo.
Dynamic redistribution of RNA polymerase II onthe
MKP-1 geneduring stimulation ofits transcription
Density of pol II on the MKP-1 gene was quantiﬁed by
ChIP using an antibody against the N-terminal region
of Rbp-1, the largest subunit of pol II (Figure 2B).
For this purpose, we prepared cross-linked and
fragmented chromatin from GH4C1 cells collected at
various times following TRH stimulation and immuno-
precipitated the DNA fragments associated with pol II.
DNA corresponding to the MKP-1 gene was then
quantiﬁed by real-time PCR. Using three primer sets
Figure 1. MKP-1 nascent transcripts after induction by TRH.
Nascent transcripts of MKP-1 were puriﬁed from chromatin
prepared from GH4C1 cells collected at various times after stimula-
tion of 100nM TRH. Transcripts which include MKP-1 exon 1, exon
2 and exon 4 sequences were quantiﬁed by real-time RT-PCR.
A typical experiment repeated twice (mean SD in triplicates) is
shown.
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this ChIP design yielded the relative density of pol II and
of the elongation factors on three important sectors of
the MKP-1 gene: the exon 1 primer set, centered at þ58
representing the sector adjacent to the transcription start
site upstream of the 5block to elongation4; the exon
1b primer set, centered at þ257 which is around
the 5block to elongation4; the exon 4 primer set,
centered at þ2076, representing the 30 region of the
MKP-1 gene.
In resting cells, pol II is already strongly associated
with exon 1 and to a lesser extent with exon 1b and least
with exon 4. During acute TRH induction (12min) pol II
is strongly recruited to all the three sectors tested.
The strongest relative increase in pol II (4-fold) is seen
on exon 4. In the stimulated steady state, the elevated
transcription rate (Figure 1) corresponds to a marked
presence of pol II on exon 4 maintained for 48min.
These dynamic changes in pol II density along the MKP-1
gene during the diﬀerent phases of TRH induction
suggest that initiation of transcription and elongation of
transcripts are independently regulated. Furthermore,
the marked presence of pol II on exon 1 prior to any
stimulation is consistent with the proposed 5block to
elongation4 in the middle of exon 1 arresting pol II in
resting cells (18).
Figure 2. Association of pol II, NELF, DSIF and P-TEFb with the MKP-1 gene. (A) Rat MKP-1 genomic locus with the primer positions. (B–E)
Distributions of pol II and elongation factors on the MKP-1 gene. ChIP assay was performed with an anti-pol II (N-20) (B), an anti-NELF-A (C),
an anti-Spt5 (D) and an anti-cyclin T1 antibody (E) with chromatin prepared at various time points of TRH stimulation. Density on the MKP-1 gene
was quantiﬁed by real-time PCR and presented as a percentage of input. A typical experiment (mean SD, n¼3) repeated three times is shown.
(F) Suppression of MKP-1 transcription by DRB an inhibitor of P-TEFb. Cells were incubated with or without 30mM DRB for 2h prior to TRH
stimulation. Total RNA was extracted 24 and 48min after TRH, and transcripts of the MKP-1 were quantiﬁed by real-time PCR. A typical
experiment repeated three times (mean SD in triplicates) is shown.
1010 Nucleic Acids Research, 2006, Vol. 35, No. 3Differential association of NELF,DSIF and P-TEFb with
the polII complextranscribing theMKP-1 gene invivo
To address the role of negative (NELF, DSIF) and
positive (P-TEFb) transcription factors in the induction
of the MKP-1 gene, we determined the in vivo association
of NELF, DSIF and P-TEFb with the MKP-1 gene during
stimulation of its transcription. Density of the elongation
factors was assessed with ChIP using antibodies against
NELF (NELF-A), DSIF (Spt5) and P-TEFb (cyclin T1).
First, we focused on the negative elongation factor
NELF which consists of four subunits (A, B, C or D and
E), all required for NELF to function as a negative
elongation factor (28–30). We examined the association
of NELF by using an anti-NELF-A antibody (Figure 2C).
In resting cells, NELF was associated with the MKP-1
gene at exon 1 and also exon 1b regions. NELF
association with exon 1 increased only very slightly
during TRH stimulation. There was no speciﬁc associa-
tion of NELF with the exon 4 of the MKP-1 gene
(compare speciﬁc versus mock in Figure 2C) regardless
of TRH stimulation. Thus, NELF is never recruited to
the 30 region and functions mainly at the promoter-
proximal regions of the MKP-1 gene.
DSIF which consists of Spt5 and Spt4 is reported to
cooperate with NELF as a negative regulator for the
arrest of pol II in vitro (28–30). Notably however,
the distribution of DSIF assessed by ChIP using an anti-
Spt5 antibody was markedly diﬀerent from that of NELF
(Figure 2C versus 2D). In resting cells, DSIF was present
at exon 1 and exon 1b and to a lesser extent even at exon 4.
In contrast to NELF the distribution of which did not
change after TRH stimulation, DSIF density changed
markedly and dynamically during TRH stimulation. On
exon 1b and exon 4, DSIF density was more than doubled
at the peak of transcriptional rate (12min). Even at the
steady state of sustained stimulated transcription (48min),
DSIF on exon 1b and exon 4 was still signiﬁcantly
increased over resting levels. Taken together, these results
lead us to postulate that NELF and DSIF act as a
complex at the promoter-proximal region to arrest pol II
elongation in resting cells; TRH stimulation separates the
complex. Strikingly, the dynamics of redistribution of
DSIF on the MKP-1 gene were very similar to that of total
pol II (Figure 2B versus 2D), suggesting that following its
dissociation from NELF, DSIF remains associated with
pol II on the transcribed MKP-1 gene during transcrip-
tional elongation.
P-TEFb which consists of cyclin T1 and the cyclin-
dependent kinase 9 (CDK9) plays a key role during the
stimulation of elongation. Indeed, in vitro it has been
shown to phosphorylate both the CTD of pol II and the
CTRs of Spt5 eliminating thereby the negative action of
the DSIF–NELF complex on transcriptional elongation
by pol II (36, 38–45). The distribution of P-TEFb on the
transcribed MKP-1 gene was assessed by ChIP assay
with an anti-cyclin T1 antibody (Figure 2E). A small
amount of P-TEFb was present on all regions (exon 1,
exon1b and exon 4) prior to TRH stimulation. TRH
caused a marked recruitment to all parts of the gene.
P-TEFb was recruited most abundantly at the peak
of transcriptional rate (12min); subsequently P-TEFb
density was reduced but its levels at the steady-state rate of
transcription (48min) remained signiﬁcantly elevated over
the initial levels prior to TRH stimulation. Densities of
pol II and P-TEFb change with similar dynamics
(Figure 2E versus 2B). This is consistent with a continuous
association of pol II and P-TEFb during stimulated
transcription of MKP-1. The data on P-TEFb recruitment
are strongly suggesting that P-TEFb plays its role to favor
transcriptional elongation also in intact cells in vivo.
The CDK9 inhibitorDRB represses MKP-1 transcription
To examine whether CDK9 activity of P-TEFb is required
for the induction of MKP-1 transcription in vivo, protein
kinase activity of CDK9 was inhibited by DRB. As
reported earlier (18) and expected from Figure 1, MKP-1
mRNA levels were dramatically increased by TRH
stimulation: 25- and 15-fold over basal at 24 and 48min
after stimulation, respectively (Figure 2F). However, in
GH4C1 cells treated with DRB prior to TRH stimulation,
the induction of MKP-1 mRNA was almost completely
suppressed such that the levels in the presence of DRB
24min after TRH stimulation were only 10% of the levels
reached in cells in which CDK9 was not inhibited.
This result clearly shows that CDK9 in P-TEFb is
essential for the induced transcription of MKP-1 gene.
Agene-specific mechanism controls stimulated recruitment
ofelongation factors tothe MKP-1 gene
To examine whether TRH stimulated speciﬁcally the
recruitment of elongation factors to the MKP-1 gene,
we assessed densities of pol II and P-TEFb also on the
housekeeping gene GAPDH. P-TEFb densities on
GAPDH were found lower, unaﬀected by TRH stimula-
tion and insensitive to inhibition of CDK-9 by DRB
(see supplementary data). However, the low levels
of P-TEFb correspond to similarly low levels of
pol II. Thus mechanisms which control transcription
elongation involving elongation factors such as P-TEFb
are likely common to all genes. However, the rapid and
reversible recruitment of elongation factors upon cell
stimulation occurs speciﬁcally on induced genes such
as MKP-1.
DRB inhibits theassociation ofP-TEFb and DSIF,
butnot ofNELF to theMKP-1 gene
To assess the role of CDK9 activity, we further
investigated the density of NELF, DSIF and P-TEFb
on the MKP-1 gene during TRH stimulation under DRB
treatment. DRB had no signiﬁcant eﬀect on the distribu-
tion of NELF which functions at the promoter-proximal
region (Figure 3A). In contrast, the association of DSIF
with the MKP-1 gene was very sensitive to DRB
(Figure 3B). While the density of DSIF on exon 1 was
essentially unaﬀected by DRB treatment neither in basal
nor in stimulated conditions, DSIF densities at exon
1b and exon 4 after TRH stimulation were reduced to less
than 50% of control by DRB. CDK9 activity is thus
not important for the recruitment of DSIF to exon 1 of
MKP-1; however the marked TRH-induced recruitment
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with stimulated transcriptional elongation depends upon
CDK9 activity.
DRB also signiﬁcantly decreased TRH-induced
recruitment of P-TEFb to the whole of the MKP-1 gene.
Whereas P-TEFb densities in resting cells were not
aﬀected by DRB, the recruitment induced by the
stimulation was reduced to less than 30% of control by
DRB (Figure 3C). Therefore, kinase activity of CDK9
is essential for the induced recruitment of the whole
P-TEFb complex to the MKP-1 gene. DRB by inhibiting
CDK9 inhibits the association of P-TEFb with pol II
and thereby the progression of pol II as well as the
progression of DSIF with pol II and P-TEFb to the
downstream parts of the MKP-1 gene.
Dynamics of phosphorylation ofSer-2 ofpol IICTD upon
TRH stimulation are linked totranscriptional elongation
To study the eﬀects of CTD phosphorylation by P-TEFb
in the context of MKP-1 transcriptional elongation, we
investigated distribution of CTD-phosphorylated pol II
on the MKP-1 gene in the presence or absence of DRB. As
shown in Figure 4A, in resting cells condition,
the association of total pol II was unaﬀected by DRB.
At the peak of transcriptional rate 12min after TRH
stimulation, the recruitment of total pol II at exon 1
region was suppressed only slightly by DRB ( 20% less
than the condition without DRB treatment). In contrast,
the association of total pol II with the exon 1b and
exon 4 regions was markedly reduced by DRB to around
one-third of the corresponding controls, indicating
that transcriptional elongation by pol II induced
by TRH stimulation was attenuated in the presence
of DRB.
The distribution of pol II phosphorylated on the Ser-5
residues of the CTD was assessed by ChIP using the
H14 antibody which recognizes the phospho-Ser-5
CTD heptad repeats (Figure 4B). The distribution
of Ser-5-phosphorylated CTD was almost identical to
that of total pol II regardless of DRB treatment.
This result suggests that the decreased association of
Ser-5-phosphorylated CTD along the gene following DRB
treatment reﬂects strictly the reduction of total pol II.
Consistent with this, the constitutive association of pol II
Ser-5-phosphorylated on its CTD with the region
upstream of the 5block to elongation4 (exon 1) should
not be signiﬁcantly aﬀected by DRB, which is indeed
the case.
In contrast, the distribution of Ser-2-phosphorylated
CTD was quite diﬀerent from that of total pol II
(Figure 4C versus 4A). ChIP assay using a phosphorylated
Ser-2-speciﬁc antibody showed that pol-II-associated exon
1 is not Ser-2-phosphorylated prior to stimulation
(Figure 4C, compare signal to mock). At the peak of
transcriptional rate 12min after TRH, Ser-2 phosphoryla-
tion was substantial on pol II situated along the whole of
the MKP-1 gene, but most abundant at the exon 4 region.
DRB prevented completely the Ser-2-phosphorylation
of pol II associated with the MKP-1 gene. The essential
role of P-TEFb for MKP-1 transcriptional elongation
(Figure 2F), and the dynamics of Ser-2 phosphorylation
of pol II transcribing the MKP-1 gene (Figure 4) are
strong indicators for an essential role of Ser-2 phosphor-
ylation for stimulated transcriptional elongation on the
MKP-1 gene in vivo. Consistent with earlier studies
in yeast attesting to the importance of Ser-2 phosphoryla-
tion for elongation (40), this suggests that P-TEFb
phosphorylation of Ser-2 is a key control element for
pol II transcription of MKP-1 and probably other
genes which are regulated at the elongation steps in
mammalian cells.
Figure 3. DRB inhibits recruitment of P-TEFb and dynamic redis-
tribution of DSIF on the MKP-1 gene. Densities of NELF, DSIF and
P-TEFb on the MKP-1 gene were assessed at various time points of
TRH stimulation in the absence (ﬁlled bars) or presence (hatched bars)
of DRB. ChIP assay was performed with an anti-NELF-A (A), an anti-
Spt5 (B) and an anti-cyclin T1 antibody (C). Density on the MKP-1
gene was analyzed by real-time PCR and presented as a percentage
of input. A typical experiment (mean SD, n¼3) repeated three times
is shown.
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Biochemical data shows that the DSIF–NELF complex
can induce the arrest of pol II, and P-TEFb allows pol II
to override such negative regulation in vitro (25–30).
However, it is less clear how and for what genes the
DSIF–NELF complex functions in vivo. The association
of NELF, DSIF and P-TEFb with pol II transcribing heat
shock genes in Drosophila has been demonstrated (31–33).
More recently, Yamada et al. showed that Spt5
phosphorylation is important for EGF activation of
c-fos transcription (36). Here, we provide the ﬁrst evidence
that the DSIF–NELF complex regulates the elongation by
pol II of the MKP-1 gene in mammalian cells. Our data
strongly support a central role of P-TEFb as a positive
elongation factor acting by modulating the function of
the DSIF–NELF complex causing its dissociation and
the association of DSIF with pol II during stimulated
transcriptional elongation in vivo.
Association ofthe DSIF–NELF complex and P-TEFb
atthe promoter-proximal region
The MKP-1 promoter functions as a constitutive
promoter, and MKP-1 transcription is presumably
controlled at the level of transcriptional elongation
(17,18,46). In the absence of stimulation, MKP-1
transcription is prematurely arrested within the ﬁrst
exon. This ﬁnding led to the hypothesis of a 5block to
elongation4, a notion that has remained without any
molecular equivalent so far. Here, we asked which factors
regulate positively and negatively the transcriptional
elongation of the MKP-1 gene? Since pol II cannot
progress on some model genes in vitro when it is paused
by the negative elongation factors, DSIF and NELF
(26,28–30), these were prime candidate negative regula-
tors. Indeed, the DSIF–NELF complex associated with
MKP-1 gene in basal condition in vivo. The limited
association of P-TEFb with the MKP-1 gene in basal
conditions (Figure 2E) and a powerful and gene-speciﬁc
inhibition of induced MKP-1 transcription by DRB
(Figures 2F and 3) are in agreement with a model whereby
the DSIF–NELF complex arrests pol II on the MKP-1
gene preventing elongation as long as P-TEFb is either not
activated, or inhibited by DRB (26,28–30).
Nuclear run-on experiments have localized the
presumed5block to elongation4at around 300bp down-
stream from the transcription start site of the MKP-1 gene
(18); given the bias of in vitro elongation of transcripts,
this technique may not correspond to the most frequent
arrest position of pol II (19). Indeed, our ChIP data
indicated that prior to stimulation, the DSIF–NELF
complex is found preferentially in the promoter-proximal
region (Figures 2 and 3). Therefore, the inhibitory
DSIF–NELF complex would function at the promoter-
proximal region in vivo similar to its behavior in vitro (28).
Upon TRH stimulation, P-TEFb is recruited to the
promoter-proximal region (Figures 2 and 3), suggesting
that P-TEFb enables pol II to override the arrest
by the DSIF–NELF complex. P-TEFb and DSIF–
NELF acting upstream leaves the question open whether
the 5block to elongation4 contains any regulatory
sequences.
Adualrole ofDSIF
DSIF does not only functions as a negative elongation
factor. Spt4 and Spt5 are essential for transcription and
cellular viability in yeast (47–50). DSIF localizes at a
large number of transcriptionally active chromosomal
sites on polytene chromosomes in Drosophila (31–33).
DSIF is necessary for appropriate RNA splicing and
transcriptional termination (51,52). Additionally, DSIF
Figure 4. Phosphorylation by P-TEFb of Serine-2 in the CTD pol II
is essential for transcriptional elongation. The density of total and
CTD-phosphorylated pol II on the MKP-1 gene was assessed at various
time points of TRH stimulation in the absence (ﬁlled bars) or presence
(hatched bars) of the DRB. ChIP assay was performed with speciﬁc
anti-pol II antibodies: (A) an anti-pol II antibody (N-20), which
recognizes N-terminal region of pol II; (B) an anti-pol II antibody
(H14), directed against phospho-Ser-5 CTD; and (C) an anti-pol II
antibody (H5), directed against phospho-Ser-2 CTD. Density on the
MKP-1 gene was quantiﬁed by real-time PCR and is presented as a
percentage of input. A typical experiment (mean SD, n¼3) repeated
three times is shown.
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human immunodeﬁciency virus (HIV) type 1 Tat in vitro
(53). Thus DSIF also functions positively
during transcriptional elongation. Spt5 is phosphorylated
by P-TEFb on its CTR (36,39,42). Phosphorylation of
the threonine 4 residues has been shown to be critical
for processive transcriptional elongation. Over-expression
of exogenous Spt5 mutated at the threonines in the
CTR reduces EGF induced c-fos gene transcription by
pol II in vivo (36). Since c-fos transcription is controlled
at the elongation steps (46) this strongly suggests that after
phosphorylation by P-TEFb of Spt5, DSIF becomes a
positive elongation factor. We show here that endogenous
DSIF migrates along the MKP-1 gene after TRH
stimulation. TRH-induced association of DSIF with
downstream parts of the MKP-1 gene was suppressed
by DRB (Figure 3), whereas the presence of DSIF on
the promoter-proximal region was not aﬀected by the
blockade of P-TEFb. Thus DSIF plays a dual role
for elongation switching from a negative to a positive
function as a consequence of the P-TEFb-dependent
phosphorylation of the CTR of Spt5.
The dynamic redistribution of DSIF along the MKP-1
gene is in marked contrast to the static presence of NELF
on the MKP-1 promoter-proximal regions. NELF is
neither aﬀected by TRH stimulation, nor by the inhibition
of CDK9 by DRB. While it has been reported that
NELF-E is phosphorylated by P-TEFb (54), our data
underline that NELF functions only as a negative
regulator at the promoter-proximal region on the
MKP-1 gene irrespective of the action of P-TEFb.
The data of our in vivo study is consistent with the
model proposed earlier derived mainly from in vitro data
(36) in which the DSIF–NELF complex would function
as a negative regulator at the promoter-proximal region
in basal condition, whereas DSIF detached from NELF
and phosphorylated on its CTR would favor stimulated
transcription.
Duringstimulated transcriptional elongation, the C-terminal
domainof polII isphosphorylated by P-TEFb on Serine-2
residues
Phosphorylation of the CTD of pol II is of key importance
for the control of RNA production and maturation. The
CTD is a lengthy extension consisting of multiple repeats
of a seven amino acid motif which includes ﬁve potential
phosphate acceptor sites. CTD is an essential element for
most of the steps leading to mature mRNA. Speciﬁc
phosphorylation of the CTD characterizes the pol II in
various stages of progression from the promoter to the
end of the transcribed gene. In view of the complexity of
potential CTD phosphorylation pattern, the term ‘CTD-
code’ has been coined (55) to illustrate that each of the
multiple functions assigned to the CTD could require
its speciﬁc pattern of multiple phosphorylation. Here,
we concentrated on the phosphorylation of the serines in
position 2 and 5 (Ser-2 and Ser-5) and its relation
to stimulated elongation involving CDK9, the kinase in
P-TEFb. Our data show very clearly that in the context of
stimulated elongation in vivo, CDK9 phosphorylates
mainly the Ser-2 residues on pol II which transcribes the
MKP-1 gene (Figure 4). Indeed, we ﬁnd Ser-2 phosphory-
lated pol II on the downstream parts of the MKP-1 gene
only during stimulated transcriptional elongation, but
neither in the basal state nor when CDK9 is inhibited by
DRB. In contrast, Ser-5 phosphorylation is found prior to
stimulation on the pol II on exon 1 of the MKP-1 gene in a
manner independent of DRB. Distribution pattern of
Ser-5-phosphorylated pol II change in parallel to the
distribution pattern of total pol II upon stimulation with
TRH; as DRB inhibits elongation both total pol II and
Ser-5 phosphorylated pol II are reduced in parallel
downstream of the 5block to elongation4. In marked
contrast, DRB inhibition of CDK9 completely prevents
Ser-2 phosphorylation, reducing ChIP with the H5
antibody to the level of mock IP.
Taken together, our data are thus consistent with the
proposal made earlier that phosphorylation of Ser-5
and Ser-2 of CTD are responsible for pol II initiation
and elongation, respectively (20–24). Note that these
ﬁndings do not deﬁne the 5CTD code4 which will
5unlock4 blocked elongation, but they strongly suggest
that phospho-Ser-2 is a necessary feature.
Continuous regulatory input byP-TEFb associated with
elongating pol II
The precise mechanisms which link signaling cascades
to elongation control via the three factors P-TEFb,
DSIF and NELF remain to be established. Possibilities
for gene-speciﬁc recruitment of elongation factors (e.g. 34)
have been recently reviewed (56) and include interactions
with RNA-binding proteins or with DNA-binding
transcription factors such as NFkB (57) or the estrogen
receptor (58).
The TRH-induced association of P-TEFb with exon 1b
and exon 4 regions suggests that P-TEFb regulates pol II
elongation along the MKP-1 gene by migrating together
with pol II after its recruitment to the promoter-proximal
region. Against a hypothetical background of constitutive
dephosphorylation of both pol II CTD (23) and Spt5 CTR
the continuous presence of P-TEFb in the transcribing
complex would assure a continuous regulatory input and
as a result ﬁnely tuned transcriptional rates. Alternatively,
P-TEFb may be required for the recruitment and
phosphorylation of proteins involved in RNA splicing,
capping and polyadenylation.
CONCLUSIONS
In Figure 5, we present a model of how transcriptional
elongation of the MKP-1 gene involves the elongation
factors NELF, DSIF and P-TEFb. In basal condition,
the DSIF–NELF complex arrests pol II elongation at
the promoter-proximal region. TRH stimulation results
in the recruitment of P-TEFb which will phosphorylate
CTR of Spt5 and Ser-2 of pol II CTD, resulting in
the functional change of DSIF and release of pol II from
the arrest. P-TEFb and DSIF detached from NELF
move together with pol II probably to promote further
1014 Nucleic Acids Research, 2006, Vol. 35, No. 3elongation of transcripts and processing of nascent
RNA into mature mRNA.
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